Albert David Ltd
Fri 29/08/2025,15:41:11 | NSE : ALBERTDAVD
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 799.35
Previous Close
₹ 795.75
Volume
1619
Mkt Cap ( Rs. Cr)
₹457.37
High
₹ 810.10
Low
₹ 794.00
52 Week High
₹ 1753.95
52 Week Low
₹ 762.60
Book Value Per Share
₹ 724.06
Dividend Yield
0.62
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Albert David Ltd
Your Vote -
Buy
81.82%
Hold
9.09%
Sell
9.09%
81.82%
22 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
801.40
212
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
212
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Albert David Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Albert David Ltd - Change in Director(s)
-
Albert David Ltd - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Albert David Ltd - Copy of Newspaper Publication
-
Albert David Ltd - Shareholders meeting
-
Albert David Ltd - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
-
Albert David Ltd - Copy of Newspaper Publication
-
Albert David Ltd - Shareholders meeting
-
Albert David Ltd - Shareholders meeting
-
Albert David Ltd - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Albert David Ltd - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Albert David Ltd - Integrated Filing- Financial
-
Albert David Ltd - Outcome of Board Meeting
-
Albert David Ltd - Change in Management
-
Albert David Ltd - Outcome of Board Meeting
-
Albert David Ltd - Announcement under Regulation 30 (LODR)-Change in Management
-
Albert David Ltd - Unaudited Financial Results For 1St Quarter Ended 30Th June,2025
-
Albert David Ltd Q1 net profit down 57.86% at Rs 7.94 cr
-
Albert David Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held On 02.08.2025.
-
Albert David Ltd - Board Meeting Intimation for To Consider, Approve, And Take On Record The Unaudited Financial Results Of T
-
Albert David Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025
-
Albert David Ltd - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Albert David Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Albert David Ltd - Copy of Newspaper Publication
-
Albert David Ltd - Notice Of Shareholders Meetings-XBRL
-
Albert David Ltd - Notice Of Annual General Meeting For Financial Year 2024-2025
-
Albert David Ltd - Shareholders meeting
-
Albert David Ltd - Reg. 34 (1) Annual Report.
-
Albert David Ltd - Copy of Newspaper Publication
-
Albert David Ltd - Updates
-
Albert David Ltd - Regulation 30 (LODR) Regulations, 2015
-
Albert David Ltd - Trading Window-XBRL
-
Albert David Ltd - Trading Window
-
Albert David Ltd - General Updates
-
Albert David Ltd - Credit Rating- Revision
-
Albert David Ltd - Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations
-
Albert David Ltd - Announcement under Regulation 30 (LODR)-Credit Rating
-
Albert David Ltd has declared 50% Final dividend for the financial year March 2025
Key fundamentals
Evaluate the intrinsic value of Albert David Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 402.5326 | 385.0809 | 315.5417 | 283.2368 | 244.8149 |
| Liabilities | 402.5326 | 385.0809 | 315.5417 | 283.2368 | 244.8149 |
| Equity | 5.7072 | 5.7072 | 5.7072 | 5.7072 | 5.7072 |
| Gross Profit | 3.0263 | 46.8796 | 44.3433 | 40.7942 | 19.1484 |
| Net Profit | 17.2008 | 75.4201 | 36.1749 | 35.2583 | 22.143 |
| Cash From Operating Activities | -28.4358 | 45.5022 | 10.515 | 40.3647 | 36.6107 |
| NPM(%) | 4.97 | 20.8 | 10.59 | 11.24 | 8.94 |
| Revenue | 345.768 | 362.4617 | 341.5644 | 313.5114 | 247.4499 |
| Expenses | 342.7417 | 315.5821 | 297.2211 | 272.7172 | 228.3015 |
| ROE(%) | 4.16 | 18.25 | 8.75 | 8.53 | 5.35 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 25 Jul 2025 | 5 | 50 | 0.62 | 884 |
| 02 Aug 2024 | 11.5 | 115 | 0.62 | 1201.95 |
| 03 Aug 2023 | 9 | 90 | 0.62 | 596.4 |
| 01 Aug 2022 | 9 | 90 | 0.62 | 545.85 |
| 06 Sep 2021 | 6 | 60 | 0.62 | 513.4 |
| 13 Mar 2020 | 7 | 70 | 0.62 | 411.35 |
| 01 Aug 2019 | 6 | 60 | 0.62 | 490.55 |
| 24 Aug 2018 | 5.5 | 55 | 0.62 | 388 |
| 01 Sep 2017 | 5.5 | 55 | 0.62 | 316.55 |
Peers
Other companies within the same industry or sector that are comparable to Albert David Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Lotus Eye Hospital and Institute Ltd | 116.84 | 6.98 | 376.90 | 1663.70 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 12.24 | -0.81 | 408.00 | 857.54 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 872.70 | 1.80 | 0.00 | 1568.91 | -604.77 | 0.00 |
| Suraksha Diagnostic Ltd | 298.00 | -1.81 | 46.64 | 4166.48 | 305.53 | 0.00 |
Company Info
The company is engaged in the manufacture of bulk drugs. The company at present manufactures herbal drugs and hypodermic disposable syringes plans to launch the production of broad spectrum antibiotics Ciprofloxacin both in tablet and injection form. The Commonwealth of Independent States states that "For setting up a Joint Venture project for the manufacture of bulk drugs, the company is also tapping on expansion & diversification of its three Units at Calcutta, Ghaziabad and Mandideep in U.P. and proposes to send Rs.30 crores in the next 3 years on this expansion programme. The company has exported anti-biotics worth of Rs.3 crores to Srilanka, Nigeria and few European countries. 2005 - Albert David Limited has entered into an agreement with Japanese chemicals company Ajinomoto Co Inc. Ajinomoto, a leading global manufacturer of amino acids, will provide technical knowhow for developing amino acid based products and will also give Albert David the rights to sell Ajinomoto's products in India. - The company has recommended a dividend at the rate of 20% per ordinary shares of Rs 10/- each for the financial year ended. 2006 - The company has recommended dividend at the rate of 25% per ordinary shares of Rs 10/- each for the financial year ended. 2007 - The company has recommends for payment of dividend @ 30% on Equity Shares of Rs 10/- each. 2008 - The company appointed Mr. Arun Kumar Kohari, Chairman, as also Managing Director. 2009 - The company has recommended for payment of dividend of Rs 3.50 per equity share of Rs 10/- each on 5707162 Equity Shares. 2010 - The company has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each on 5707162 Equity Shares. 2011 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2012 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2013 -Albert David Ltd has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each. 2014 -Albert David Ltd has appointed Mr. Arindam Sarkar as Additional Director of the Company. -Albert David Ltd have recommended dividend of Rs. 5.00 per equity share of Rs. 10/- each.
The company is engaged in the manufacture of bulk drugs. The company at present manufactures herbal drugs and hypodermic disposable syringes plans to launch the production of broad spectrum antibiotics Ciprofloxacin both in tablet and injection form. The Commonwealth of Independent States states that "For setting up a Joint Venture project for the manufacture of bulk drugs, the company is also tapping on expansion & diversification of its three Units at Calcutta, Ghaziabad and Mandideep in U.P. and proposes to send Rs.30 crores in the next 3 years on this expansion programme. The company has exported anti-biotics worth of Rs.3 crores to Srilanka, Nigeria and few European countries. 2005 - Albert David Limited has entered into an agreement with Japanese chemicals company Ajinomoto Co Inc. Ajinomoto, a leading global manufacturer of amino acids, will provide technical knowhow for developing amino acid based products and will also give Albert David the rights to sell Ajinomoto's products in India. - The company has recommended a dividend at the rate of 20% per ordinary shares of Rs 10/- each for the financial year ended. 2006 - The company has recommended dividend at the rate of 25% per ordinary shares of Rs 10/- each for the financial year ended. 2007 - The company has recommends for payment of dividend @ 30% on Equity Shares of Rs 10/- each. 2008 - The company appointed Mr. Arun Kumar Kohari, Chairman, as also Managing Director. 2009 - The company has recommended for payment of dividend of Rs 3.50 per equity share of Rs 10/- each on 5707162 Equity Shares. 2010 - The company has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each on 5707162 Equity Shares. 2011 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2012 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2013 -Albert David Ltd has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each. 2014 -Albert David Ltd has appointed Mr. Arindam Sarkar as Additional Director of the Company. -Albert David Ltd have recommended dividend of Rs. 5.00 per equity share of Rs. 10/- each.
Read More
Parent Organisation
Albert David Ltd.
Founded
16/11/1938
Managing Director
Mr.Umesh Manohar Kunte
NSE Symbol
ALBERTDAVDEQ
FAQ
The current price of Albert David Ltd is ₹ 801.40.
The 52-week high for Albert David Ltd is ₹ 810.10 and the 52-week low is ₹ 794.00.
The market capitalization of Albert David Ltd is currently ₹ 457.37. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Albert David Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Albert David Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Albert David Ltd shares.
The CEO of Albert David Ltd is Mr.Umesh Manohar Kunte, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
